Alliance trial A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas
      Google Scholar   
Citation:
J Clin Oncol vol 39 (suppl 3) abstr 419
Meeting Instance:
ASCO GI 2021
Year:
2021
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
3693   4071  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171 ; U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);  
Corr. Author:
 
Authors:
                                     
Networks:
CA043, CA824, IL018, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-OH007, LAPS-TX035, MD015, NORTHWELL, OH070, PCRC   
Study
Alliance-A021501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: